Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Mn-promoted synthesis of indole-isoquinolinone derivatives. High yield, mild conditions. Cost-effective solution for API intermediates.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction and scalable supply chain reliability.
Patent CN112028841A reveals a catalyst-free visible light method for high-yield quinoxalinone synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116143689A details a metal-free route to tetrasubstituted pyridines using imidazole hydrochloride, offering high yields and scalability for pharmaceutical intermediates.
Novel patent CN113651788B enables efficient room temperature synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity and cost-effective synthesis for asymmetric catalysis.
Patent CN112225657B reveals a green aqueous Suzuki coupling for Flurbiprofen. Discover cost-effective manufacturing and high-purity supply chain solutions.
Novel iron-catalyzed asymmetric hydrogenation technology using chiral quinoline imidazoline ligands. Reduces noble metal dependency for high-purity pharmaceutical intermediates.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN107021866A details a Lewis acid catalyzed route for chain enyne compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel oxindole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions for fine chemical manufacturing.
Novel synthesis of Zn-porphyrin complexes for OLEDs. Enhanced stability and scalable phase transfer catalysis for reliable supply chain solutions.
Patent CN108794420B discloses a novel bisoxazoline ligand synthesis from cheap bisphenols, offering significant cost reduction and scalable production for asymmetric catalysis.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with scalable supply chain reliability and cost efficiency.
Patent CN114805209A details a metal-free photocatalytic route for 3-aryl-2H-indazoles using aryl sulfonium salts, offering cost reduction and supply chain reliability.
Patent CN111777564B details a green aqueous photocatalytic method for quinazolinones using KI, offering cost-effective and scalable production for pharmaceutical intermediates.
Patent CN102516300A discloses efficient phosphine ligands enabling superior enantioselectivity and simplified synthesis for cost-effective pharmaceutical intermediate manufacturing.
Patent CN114160206B details a novel chiral copper catalyst achieving >91% ee and >81% yield for 3-alkenyl-3-substituted oxindoles, offering scalable API intermediate solutions.
Patent CN113429349A details a Cu/g-C3N4 catalyzed route for high-purity benzimidazoles, offering scalable production and cost-effective manufacturing solutions.